Sunshine Biopharma (SBFM) Accounts Payables (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Accounts Payables came in at $5.1 million in Q1 2026, up 1.6% YoY from $5.0 million in Q1 2025, and down 9.88% on a QoQ basis from $5.7 million in Q4 2025.
Sunshine Biopharma (SBFM) Accounts Payables (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 16 years of Accounts Payables data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Accounts Payables rose 1.6% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 1.6% YoY) and the FY2025 annual result came in at $5.7 million, up 2.19% from the prior year.
- Accounts Payables eased to $5.1 million in Q1 2026, from $5.7 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $6.1 million in Q3 2025 to a low of $95234.0 in Q1 2022.
- A 5-year average of $3.4 million and a median of $3.6 million in 2024 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 6426.94% in 2022, down 35.9% in 2022.
- Tracing SBFM's Accounts Payables over 5 years: stood at $2.8 million in 2022, then dropped by 7.75% to $2.6 million in 2023, then soared by 114.39% to $5.5 million in 2024, then increased by 2.19% to $5.7 million in 2025, then retreated by 9.88% to $5.1 million in 2026.
- The last three Accounts Payables figures came in at $5.1 million (Q1 2026), $5.7 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.65 Bn | 39.99 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.09 Bn | 19.43 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 19.01 Bn | 18.12 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.04 Bn | 11.51 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Sunshine Biopharma | 1.59 Mn | -12.16 Mn | 2.43 Mn | 4.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.93 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 480,209.00 |
| Jun 30, 2022 | 104,684.00 |
| Mar 31, 2022 | 95,234.00 |
| Dec 31, 2021 | 42,942.00 |
| Sep 30, 2021 | 56,687.00 |